Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00659828 · ClinicalTrials.gov registry record · Phase 2
Effects of Leptin Replacement in Children
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00659828: Completed Phase 2 study, sponsored by University of Miami.
NCT00659828 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00659828, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
To assess the endocrine and immune effects of leptin replacement in leptin-deficient children, from a consanguineous family. The hypothesis is that leptin replacement will have significant effects on endocrine function.
Interventions
- DRUG Recombinant methionyl human leptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-06 |
| Est. Completion | 2010-04-16 |
| Phase | Phase 2 |
What the finished NCT00659828 record still lists
NCT00659828 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Recombinant methionyl human leptin is the first listed.
NCT00659828 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00659828 about?
NCT00659828 is a clinical study titled "Effects of Leptin Replacement in Children". To assess the endocrine and immune effects of leptin replacement in leptin-deficient children, from a consanguineous family. The hypothesis is that leptin replacement will have significant effects on endocrine function.
What is the current status of trial NCT00659828?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2005-06. Estimated completion is 2010-04-16.
What interventions are being tested in trial NCT00659828?
The interventions under investigation include: Recombinant methionyl human leptin (DRUG).
Who is sponsoring clinical trial NCT00659828?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00659828's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia